PainReform Ltd. Files 6-K Report
Ticker: PRFX · Form: 6-K · Filed: Oct 1, 2025 · CIK: 1801834
| Field | Detail |
|---|---|
| Company | Painreform Ltd. (PRFX) |
| Form Type | 6-K |
| Filed Date | Oct 1, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, registration-statement
TL;DR
PainReform filed a 6-K, incorporating into existing S-8/F-3 filings. Nothing new, just housekeeping.
AI Summary
PainReform Ltd. filed a Form 6-K on October 1, 2025, reporting for the period ending June 30, 2025. This filing incorporates by reference information into several of the company's existing registration statements on Form S-8 and Form F-3. The company is a foreign private issuer based in Tel Aviv, Israel, and operates in the pharmaceutical preparations sector.
Why It Matters
This filing updates the company's reporting status and incorporates information into existing registration statements, which can be relevant for investors tracking the company's ongoing compliance and potential future offerings.
Risk Assessment
Risk Level: low — This filing is primarily a routine report and incorporation by reference, not indicating new material events or financial distress.
Key Players & Entities
- PainReform Ltd. (company) — Filer of the 6-K report
- 001-39481 (company) — Commission File Number for PainReform Ltd.
- 333-257968 (company) — Registration Statement on Form S-8
- 333-265902 (company) — Registration Statement on Form S-8
- 333-282264 (company) — Registration Statement on Form F-3
- 333-254982 (company) — Registration Statement on Form F-3
- 333-276485 (company) — Registration Statement on Form F-3
- 333-277594 (company) — Registration Statement on Form F-3
- 333-283655 (company) — Registration Statement on Form F-3
- 333-286941 (company) — Registration Statement on Form F-3
FAQ
What period does this Form 6-K report cover?
This Form 6-K reports for the month of October 2025 and is conformed for the period of report ending June 30, 2025.
What is the company's principal executive office address?
The company's principal executive offices are located at 65 Yigal Alon St., Tel Aviv, 6744316, Israel.
What type of registration statements does this 6-K filing incorporate into?
This 6-K filing is incorporated by reference into the Company's Registration Statements on Form S-8 (Registration No. 333-257968 and 333-265902) and Form F-3 (Registration No. 333-282264, 333-254982, 333-276485, 333-277594, 333-283655 and 333-286941).
Is PainReform Ltd. required to file annual reports on Form 20-F or 40-F?
Yes, PainReform Ltd. indicates it files annual reports under cover of Form 20-F.
What is the SIC code for PainReform Ltd.?
The Standard Industrial Classification (SIC) code for PainReform Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 519 words · 2 min read · ~2 pages · Grade level 9.7 · Accepted 2025-10-01 09:29:56
Filing Documents
- zk2533811.htm (6-K) — 21KB
- exhibit_99-1.htm (EX-99.1) — 625KB
- exhibit_99-2.htm (EX-99.2) — 123KB
- exhibit_99-3.htm (EX-99.3) — 22KB
- image0.jpg (GRAPHIC) — 704KB
- 0001178913-25-003458.txt ( ) — 5706KB
- prfx-20250630.xsd (EX-101.SCH) — 76KB
- prfx-20250630_cal.xml (EX-101.CAL) — 32KB
- prfx-20250630_def.xml (EX-101.DEF) — 186KB
- prfx-20250630_lab.xml (EX-101.LAB) — 789KB
- prfx-20250630_pre.xml (EX-101.PRE) — 276KB
- zk2533811_htm.xml (XML) — 533KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 1, 2025 PAINREFORM LTD. By: /s/ Ehud Geller Ehud Geller Executive Chairman of the Board and Interim Chief Executive Officer